Association of Long-term Tacrolimus (FK506) Therapy with Abnormal Megakaryocytosis, Bone Marrow Fibrosis, and Dyserythropoiesis

Overview

Journal Clin Case Rep

Date 2015 Aug 15

PMID 26273466

Citations 2

Authors

Zhongbo Yang

Thomas Loew

Richard D Hammer

Affiliations

Soon will be listed here.

Abstract

Haematopoietic abnormalities associated with tacrolimus are relatively rare with reversible pure red cell aplasia being the most common. We report for the first time, to our best knowledge, tacrolimus therapy associated with bone marrow fibrosis, abnormal megakaryocytosis, and dyserythopoiesis in a 17-year-old male treated with tacrolimus for nephrotic syndrome.

Citing Articles

Folate Deficiency and Medication-Induced Severe Pancytopenia in a Bilateral Lung Transplantee.

Au-Yeung N, Regennitter N, Stepherson J, Seele J, Rosenblatt E, Carter W Cureus. 2024; 16(7):e65780.

PMID: 39211639 PMC: 11361740. DOI: 10.7759/cureus.65780.

Nuances of Morphology in Myelodysplastic Diseases in the Age of Molecular Diagnostics.

Shaver A, Seegmiller A Curr Hematol Malig Rep. 2017; 12(5):448-454.

PMID: 28822050 DOI: 10.1007/s11899-017-0405-y.

References

Greenbaum L, Benndorf R, Smoyer W . Childhood nephrotic syndrome--current and future therapies. Nat Rev Nephrol. 2012; 8(8):445-58. DOI: 10.1038/nrneph.2012.115. View

Jordan S, Rosenthal P, Makowka L . Immunosuppression in organ transplantation. Semin Pediatr Surg. 1993; 2(4):206-7. View

Green M, Michaels M . Tacrolimus: effects and side effects. Pediatr Infect Dis J. 1999; 18(4):372-3. DOI: 10.1097/00006454-199904000-00014. View

BASS R, Pullarkat V, Feinstein D, Kaul A, Winberg C, Brynes R . Pathology of autoimmune myelofibrosis. A report of three cases and a review of the literature. Am J Clin Pathol. 2001; 116(2):211-6. DOI: 10.1309/6Q99-VRNL-7BTP-W1G8. View

De-la-Serna-Higuera C, Marugan R, Aviles J, Nuno J, Cantalapiedra A . Tacrolimus-induced bone marrow suppression. Lancet. 1997; 350(9079):714-5. DOI: 10.1016/s0140-6736(05)63514-3. View

Churpek J, Larson R . The evolving challenge of therapy-related myeloid neoplasms. Best Pract Res Clin Haematol. 2014; 26(4):309-17. PMC: 3920194. DOI: 10.1016/j.beha.2013.09.001. View

Suzuki S, Osaka Y, Nakai I, Yasumura T, Omori Y, Yamagata N . Pure red cell aplasia induced by FK506. Transplantation. 1996; 61(5):831-2. DOI: 10.1097/00007890-199603150-00026. View

Parmentier S, Schetelig J, Lorenz K, Kramer M, Ireland R, Schuler U . Assessment of dysplastic hematopoiesis: lessons from healthy bone marrow donors. Haematologica. 2011; 97(5):723-30. PMC: 3342975. DOI: 10.3324/haematol.2011.056879. View

Giraudier S, Chagraoui H, Komura E, Barnache S, Blanchet B, Lecouedic J . Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors. Blood. 2002; 100(8):2932-40. DOI: 10.1182/blood-2002-02-0485. View

10.

Nosari A, Marbello L, De Carlis L, DE Gasperi A, Muti G, Mancini V . Bone marrow hypoplasia complicating tacrolimus (FK506) therapy. Int J Hematol. 2004; 79(2):130-2. DOI: 10.1532/ijh97.e0213. View

11.

Komura E, Tonetti C, Penard-Lacronique V, Chagraoui H, Lacout C, Lecouedic J . Role for the nuclear factor kappaB pathway in transforming growth factor-beta1 production in idiopathic myelofibrosis: possible relationship with FK506 binding protein 51 overexpression. Cancer Res. 2005; 65(8):3281-9. DOI: 10.1158/0008-5472.CAN-04-2339. View

12.

Misra S, MOORE T, Ament M, Busuttil R, McDiarmid S . Red cell aplasia in children on tacrolimus after liver transplantation. Transplantation. 1998; 65(4):575-7. DOI: 10.1097/00007890-199802270-00021. View

13.

Orazi A . Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases. Pathobiology. 2007; 74(2):97-114. DOI: 10.1159/000101709. View